XLRN
Acceleron Pharma Inc
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Market Cap: 7.09 Billion
Primary Exchange: NASDAQ/NMS (GLOBAL MARKET)
Website: http://www.acceleronpharma.com/
Shares Outstanding: 60.3 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Ethical Flags
Longest drawdown: 1195 trading days
From: 2014-01-22 To: 2018-09-19
Lowest Point:
Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis
via: Business Wire at 2019-06-10 03:00:00:000
Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today that company co-founder Tom Maniatis, PhD, is retiring from his position on its Board of Director… read more...
Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis
via: Business Wire at 2019-06-10 03:00:00:000
Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today that company co-founder Tom Maniatis, PhD, is retiring from his position on its Board of Director… read more...
Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis
via: Business Wire at 2019-06-10 03:00:00:000
Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today that company co-founder Tom Maniatis, PhD, is retiring from his position on its Board of Director… read more...
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|